← Back to Search

Imaging

Whole-body FDG PET-CT alone for Breast Cancer (PET ABC Trial)

N/A

Waitlist Available

Led By Ian Dayes, MD

Research Sponsored by Ontario Clinical Oncology Group (OCOG)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from date of randomization to date of event, assessed up to 5 years

Awards & highlights

PET ABC Trial Summary

This trial is comparing two ways of staging cancer to see which is better.

Eligible Conditions

Stage III Breast Cancer
Breast Cancer

PET ABC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from date of randomization to date of event, assessed up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from date of randomization to date of event, assessed up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of randomization to date of event, assessed up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of patients upstaged to Stage IV disease

Secondary outcome measures

Disease Free Survival

Incremental economic analysis comparing the costs and outcomes of the treatment arms

Number of additional tests, such as imaging and biopsy, resulting from findings of study imaging

+3 more

PET ABC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Whole-body FDG PET-CT aloneExperimental Treatment1 Intervention

Group II: Conventional breast cancer stagingActive Control1 Intervention

Conventional breast cancer staging consisting of a bone scan and CT imaging with contrast of the chest / abdomen & pelvis

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ontario Clinical Oncology Group (OCOG)Lead Sponsor

62 Previous Clinical Trials

41,516 Total Patients Enrolled

16 Trials studying Breast Cancer

9,118 Patients Enrolled for Breast Cancer

Cancer Care OntarioOTHER

16 Previous Clinical Trials

91,664 Total Patients Enrolled

Ian Dayes, MDPrincipal InvestigatorJuravinski Hospital and Cancer Centre

1 Previous Clinical Trials

103 Total Patients Enrolled

1 Trials studying Breast Cancer

103 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in this clinical experiment that a participant could fill?

"Clinicialtrials.gov states that this clinical trial, whose initial post date was December 6th of 2016 and was last updated on April 19th 2022, is not currently accepting patients. However, there are an additional 2289 studies presently welcoming participants into their programs."

Answered by AI

In how many distinct locations is this medical trial being conducted?

"Patients have 6 different locations to choose from, including the Juravinski Cancer Centre in Hamilton, Thunder Bay Regional Health Sciences Centre in Thunder Bay, and Sunnybrook Odette Cancer Centre in Ottawa. Additionally 3 other sites are available."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

2016. "Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02751710.